A Study of FRaDCs for Ovarian Cancer

Conditions:   Fallopian Tube Carcinosarcoma;   Primary Peritoneal Carcinosarcoma;   Recurrent Fallopian Tube Carcinoma;   Recurrent Fallopian Tube Clear Cell Adenocarcinoma;   Recurrent Fallopian Tube Endometrioid Adenocarcinoma;   Recurrent Fallopian Tube High Grade Serous Adenocarcinoma;   Recu rrent Ovarian Carcinoma;   Recurrent Ovarian Carcinosarcoma;   Recurrent Ovarian Clear Cell Adenocarcinoma;   Recurrent Ovarian Endometrioid Adenocarcinoma;   Recurrent Ovarian High Grade Serous Adenocarcinoma;   Recurrent Primary Peritoneal Carcinoma;   Recurrent Primary Periton eal Clear Cell Adenocarcinoma;   Recurrent Primary Peritoneal Endometrioid Adenocarcinoma;   Recurrent Primary Peritoneal High Grade Serous Adenocarcinoma Interventions:   Procedure: Biopsy;   Procedure: Biospecimen Collection;   Procedure: Computed Tomography;   Procedure: Magnetic Resonance Imaging;   Biological: Multi-epitope Folate Receptor Alpha-loaded Dendritic Cell Vaccine;   Biological: Pembrolizumab;   Procedure: Pheresis Sponsor:   Mayo Clinic Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials